SignatureFD’s Fulgent Genetics FLGT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$12.4K Buy
603
+7
+1% +$119 ﹤0.01% 2563
2026
Q1
$9.48K Sell
596
-1,629
-73% -$35.4K ﹤0.01% 2544
2025
Q4
$58.5K Buy
2,225
+71
+3% +$1.84K ﹤0.01% 1557
2025
Q3
$48.7K Buy
2,154
+240
+13% +$4.94K ﹤0.01% 1648
2025
Q2
$38K Buy
1,914
+721
+60% +$14.1K ﹤0.01% 1736
2025
Q1
$20.2K Buy
1,193
+215
+22% +$3.66K ﹤0.01% 2052
2024
Q4
$18.1K Sell
978
-1,246
-56% -$24.3K ﹤0.01% 2110
2024
Q3
$48.3K Sell
2,224
-1
-0% -$22 ﹤0.01% 1593
2024
Q2
$43.7K Buy
2,225
+1,132
+104% +$23.6K ﹤0.01% 1573
2024
Q1
$23.7K Buy
1,093
+154
+16% +$3.82K ﹤0.01% 1912
2023
Q4
$27.1K Buy
939
+61
+7% +$1.63K ﹤0.01% 1775
2023
Q3
$23.5K Sell
878
-28
-3% -$956 ﹤0.01% 1770
2023
Q2
$33.5K Sell
906
-352
-28% -$12.3K ﹤0.01% 1639
2023
Q1
$39.3K Buy
1,258
+625
+99% +$20.1K ﹤0.01% 1508
2022
Q4
$18.9K Buy
633
+537
+559% +$19.2K ﹤0.01% 1829
2022
Q3
$4K Buy
+96
New +$4.81K ﹤0.01% 2520
2022
Q2
Sell
-10
Closed -$1K 3183
2022
Q1
$1K Buy
+10
New +$658 ﹤0.01% 2983
2021
Q4
Sell
-21
Closed -$2K 3155
2021
Q3
$2K Buy
21
+13
+163% +$1.18K ﹤0.01% 2636
2021
Q2
$1K Buy
+8
New +$639 ﹤0.01% 2719
2021
Q1
Sell
-25
Closed -$1K 2771
2020
Q4
$1K Buy
+25
New +$1.04K ﹤0.01% 2420

Other funds holding FLGT

SignatureFD's FLGT Position: Q2 2026 in Review

SignatureFD increased its Fulgent Genetics (FLGT) stake by 1.2% in Q2 2026, buying an estimated $119 and bringing the position to 603 shares worth $12.4K. The position accounts for ﹤0.01% of the portfolio, ranked #2563.

SignatureFD first reported a position in FLGT in Q4 2020 and has held it in 20 quarters since. The position peaked at $58.5K in Q4 2025. 22 funds tracked by Wall St. Rank hold FLGT as of Q2 2026.

  • SignatureFD held 603 shares of Fulgent Genetics worth $12.4K as of Q2 2026.
  • SignatureFD bought 7 Fulgent Genetics shares in Q2 2026, an estimated $119.
  • Fulgent Genetics made up ﹤0.01% of SignatureFD's portfolio in Q2 2026, its #2563 holding.
  • SignatureFD first reported a position in Fulgent Genetics in Q4 2020 and has held it in 20 quarters since.
  • SignatureFD's Fulgent Genetics position peaked at $58.5K in Q4 2025.
  • 22 funds tracked by Wall St. Rank held Fulgent Genetics as of Q2 2026.

Based on SignatureFD's 13F filing for Q2 2026, filed 24 Jul 2026.